CSL clears hurdles to settle $16.4b Vifor deal - Sydney Morning Herald

One of our largest companies has completed a massive deal to bring cutting-edge kidney and iron deficiency drugs to Australia and the world.

The market has since embraced the possible revenue opportunities on offer from a number of new treatments in Vifors pipeline that have yet to come to market. Investors will have to wait longer for d… [+1966 chars]

full article...